Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) (IMA)
Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) is the official source of medicine shortage information for Iceland (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- lyfjastofnun.is
- Country
- Iceland
- Notices tracked by Mederti
- 3,052
- Last checked
- 15 Sept 2026
Latest notices from IMA
- Metronidazolum — active, medium, since 14 Sept 2026 (source)
- Lacosamidum — active, medium, since 14 Sept 2026 (source)
- Trifluridinum — active, low, since 14 Sept 2026 (source)
- Losartanum — active, medium, since 14 Sept 2026 (source)
- Sitagliptinum — active, low, since 14 Sept 2026 (source)
- Recombinant Human Parathyroid Hormone — active, high, since 14 Sept 2026 (source)
- Tacrolimusum — active, medium, since 14 Sept 2026 (source)
- Venlafaxinum — active, medium, since 14 Sept 2026 (source)
- Misoprostolum — active, low, since 13 Sept 2026 (source)
- Travoprostinum — active, low, since 11 Sept 2026 (source)
- Methylphenidatum — active, medium, since 10 Sept 2026 (source)
- Sildenafilum — active, medium, since 10 Sept 2026 (source)
- Flurbiprofenum — active, medium, since 10 Sept 2026 (source)
- Detomidinum — active, high, since 10 Sept 2026 (source)
- Aripiprazolum — active, medium, since 9 Sept 2026 (source)
Every IMA notice, searchable and alertable
Search Iceland's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency). All notices remain the property of their publisher and are linked to the original source.